Cite Filings / ROIV / 0001493152-26-007176

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Roivant Sciences Ltd. Filed 2026-02-17 Acc 0001493152-26-007176

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-03-06 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-20 144 Sale of Securities
2026-02-19 144 Sale of Securities
2026-02-18 4 President & Immunovant CEO sold 200,000 shares at $26.49 ($5,298,000)
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-13 4 Director sold 1,225,784 shares at an average $26.64 ($32,658,518)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…